How is Moderna creating new drug candidates? We’re using mRNA, which we think of as the software of life. It encodes the critical instructions from DNA that direct cells in the body to make ...

Messenger ribonucleic acid (mRNA), long a part of college biology textbooks, entered the public limelight with a vengeance with the development of the first Covid-19 vaccines in 2020. As an ...

Customers looking for an mRNA therapeutic partner should prioritize operational excellence and choose flexible CDMOs.

Join 50+ world-class speakers to accelerate the development of mRNA drug substance and advance drug products into the clinic and through to market, to enable scalable, cost-effective and ...

Phospholipids are key components of cell membranes, and are used in the creation of lipid nanoparticles (LNPs) for targeted drug delivery. DOPE-Cx can form a special structure called a “cubic phase,” ...

innovative manufacturing of mRNA drug substance and the LUNAR-formulated drug product. Arcturus’ lead clinical stage product candidates include a first-in-class, self-amplifying mRNA vaccine for ...

At present, over 45 industry players are engaged in the development of mRNA drug candidates for a wide range of disease indications. The success of COVID-19 vaccines, growing research activity and ...

The blood-brain barrier serves as a protective shield, preventing many substances ... higher mRNA delivery efficiency than ...